Despite a shrinking global share and punitive trade policies, Europe is attracting renewed pharmaceutical investment. Companies are betting on its regulatory rigor, regional diversification strategies, and deep scientific heritage to secure future supply chains.
As tech stocks face a brutal sell-off, veteran trader Tom Sosnoff argues the resulting volatility creates a prime environment for selective buying, particularly in beaten-down fintech names and overlooked giants.
As Regeneron Pharmaceuticals shares trade significantly off recent highs, a closer look reveals a company built for sustained innovation. With its foundational VelociSuite platform, a diversified portfolio led by Dupixent, and a fortress balance sheet, analysts argue the current valuation may not fully capture its long-term potential.
Shares of Jacobs Solutions (J) climbed over 3% after the engineering and professional services giant posted quarterly results that handily topped analyst forecasts, fueled by double-digit revenue growth and a surging project backlog.
Old Dominion Freight Line sees glimmers of a demand rebound in manufacturing data and inventory trends but warns the road to recovery may be uneven, with a clearer inflection point potentially years away.
The New York Times Company saw its stock plunge more than 8% Thursday after a mixed fourth-quarter earnings report, where disappointing profitability figures and slowing subscriber additions overshadowed better-than-expected revenue.
Shares of defense electronics firm Mercury Systems (MRCY) cratered Thursday, despite reporting Q4 results that topped analyst estimates. The steep sell-off was driven by mounting investor alarm over deteriorating operating margins and cash flow, highlighting deeper structural challenges within the business.
Shares of residential solar leader Sunrun surged over 11% after announcing the nation's largest distributed power plant, with customer participation skyrocketing more than fivefold in 2025 and delivering gigawatt-scale grid support.
Amid market volatility, one investor outlines a strategic pivot towards Brookfield Renewable, Hormel Foods, and Clorox, betting on their resilient dividends and growth potential.
Darden Restaurants, parent to Olive Garden and Longhorn Steakhouse, is closing all remaining Bahama Breeze locations, ending the Caribbean-themed chain's nearly three-decade presence. The company plans to convert the spaces to other brands within its portfolio.
Nomura Holdings clarifies that stricter position limits at its crypto unit Laser Digital aim to manage short-term earnings swings, not signal a retreat from the digital asset market, as the bank maintains its long-term commitment to the sector.
The Dallas-based engineering giant posted a dramatic turnaround to profit in its latest quarter, crediting a booming pipeline of AI-driven data center and semiconductor projects alongside strong water sector demand.
The Pan American Health Organization urges heightened surveillance and vaccination efforts as confirmed measles cases surge dramatically across the region, reversing years of progress.
A poignant national touring exhibition, born from a mother's grief for her son Oscar Grant, uses birthday remembrances to humanize victims of police brutality and examine the enduring impact on communities.
The White House has deleted and corrected a social media post that falsely accused a Honduran man of child sex offenses, marking another incident of erroneous information being disseminated amid its immigration enforcement publicity campaign.
Visa shares have retreated from recent highs, presenting a conundrum for investors. While its long-term track record remains stellar, short-term weakness and conflicting valuation signals demand a closer look at the payments giant's prospects.
CVS Health faces operational shifts as it prepares to exit a major New Jersey Medicaid pharmacy network, potentially affecting nearly 1 million members, while simultaneously confronting proposed federal rules demanding greater transparency from its Pharmacy Benefit Manager division.
Super Micro Computer's stellar Q2 earnings, fueled by AI server demand, have prompted a raised annual outlook to over $40 billion. Yet, the celebration is tempered by stark realities: margins are razor-thin, and the company's fortunes are increasingly tied to one massive data center customer, reshaping its risk profile for investors.
A coalition of major investors has filed resolutions challenging BP's pivot back toward oil and gas, demanding greater transparency on capital allocation and how the strategy aligns with earlier climate pledges ahead of the annual meeting.
Merck & Co. posted strong 2025 sales but offered a 2026 revenue forecast below Wall Street's expectations. Despite this, its shares have rallied sharply over the past year, leading analysts to question whether the market is pricing in future pipeline success or overlooking near-term headwinds.
